Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 3 18Phase 1 11Phase 1/2 3Phase 4 2Phase 2/3 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Conjunctival Intraepithelial Neoplasia 1

Interventions

Zoledronic Acid 28Saline Solution 26Metformin 25Dexamethasone 25Cyclophosphamide 23Cytarabine 22Bupivacaine 20Sodium Chloride 18Vincristine 17Methotrexate 17Letrozole 17Propofol 15Morphine 15Doxorubicin 15Prednisolone 14Docetaxel 14Dexmedetomidine 14Cisplatin 14Bevacizumab 14Oxycodone 13Imiquimod 13Fentanyl 13Capecitabine 13Rituximab 12Mercaptopurine 12Fluorouracil 12Granulocyte Colony-Stimulating Factor 11Everolimus 11Asparaginase 11Acetaminophen 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Completed × Mitomycin × Clear all
NCT03348969 2026-03-03

NICSA

Aarhus University Hospital

Phase 4 Completed
120 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT02199327 2017-08-08

Topical Interferon Alfa 2b and Mitomycin C in Conjunctival-Corneal Intraepithelial Neoplasia

Coordinación de Investigación en Salud, Mexico

Phase 4 Completed
18 enrolled

Conjunctival Intraepithelial Neoplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡